Theseus Pharmaceuticals Inc (DELISTED) (THRX:DL)
4.06
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Theseus Pharmaceuticals Total Liabilities (Quarterly): 10.10M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 10.10M |
| June 30, 2023 | 10.99M |
| March 31, 2023 | 10.13M |
| December 31, 2022 | 14.83M |
| September 30, 2022 | 11.70M |
| June 30, 2022 | 9.294M |
| Date | Value |
|---|---|
| March 31, 2022 | 9.653M |
| December 31, 2021 | 4.495M |
| September 30, 2021 | 147.76M |
| June 30, 2021 | 146.14M |
| December 31, 2020 | 42.88M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.495M
Minimum
Dec 2021
147.76M
Maximum
Sep 2021
38.00M
Average
10.99M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 9.827M |
| iBio Inc | 25.29M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 234.63M |
| Shareholders Equity (Quarterly) | 224.52M |